source
- Mineralys Therapeutics raises funds ahead of pending lorundrostat hypertension approvalMineralys Therapeutics first came to market attention in 2021 when it licensed a novel hypertension candidate, lorundrostat, from Japan’s Tanabe Pharma, agreeing to a modest $1 million upfront paym…
- Pope’s AI Encyclical Offers Guidance for Catholic Hospitals and Health CareThe article notes that Pope Francis released an encyclical addressing artificial intelligence and examines what that means for Catholic hospitals and the broader health‑care system. STAT’s AI Prog…